The Economic Burden of Vision Loss and Blindness in the United States
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
IMPORTANCE Approximately 8 million Americans self-report vision loss and blindness (VL), potentially resulting in a significant economic burden. OBJECTIVE Estimate the economic burden of VL in the US and by state. DESIGN Analysis of secondary data sources (American Community Survey (ACS), American Time Use Survey, Bureau of Labor Statistics, Medical Expenditure Panel Survey (MEPS), National and State Health Expenditure Accounts (N/SHEA), National Health Interview Survey (NHIS)) using attributable fraction, regression, and other methods to estimate the incremental direct and indirect 2017 costs of VL. PARTICIPANTS People with a yes response to a question asking if they are blind or have serious difficulty seeing even when wearing glasses in the ACS, MEPS, or NHIS. MAIN OUTCOME MEASURES We estimated the direct costs of medical, nursing home (NH), and supportive services; and indirect costs of absenteeism, lost household production, reduced labor force participation, and informal care by age group (0-18 years, 19-64 years, 65+ years), sex (male, female), and state in aggregate and per person with VL. RESULTS We estimated an economic burden of VL of $134.2bn, $98.7 bn in direct costs, and $35.5 bn in indirect costs. The most substantial burden components were NH ($41.8 bn), medical care services other than inpatient, ambulatory, and prescription care ($30.9 bn), and reduced labor force participation ($16.2 bn) which accounted for 66% of the total. Persons with VL incurred $16,838 per year in incremental burden. Informal care was the largest burden component for people ages 0-18 years, reduced labor force participation for people ages 19-64 years, and NH costs for people ages 65+ years. New York, Connecticut, Massachusetts, Rhode Island, and Vermont experienced the highest costs per person with VL. Sensitivity analyses indicate total burden may range between $76 and $218 bn depending on assumptions used in the model. CONCLUSIONS AND RELEVANCE Self-reported VL imposes a substantial economic burden on the US. Burden accrues in different ways at different ages, leading to state differences in the composition of per-person costs based on their VL population's age composition. Information on state variation can help local decision-makers better target resources to address the burden of VL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Equivalence of two healthcare costing methods: bottom-up and top-down
Chapko, M. K., Liu, C., Perkins, M., Li, Y., Fortney, J. C., & Maciejewski, M. L. (2009) · Health Economics · doi:10.1002/hec.1422 · Cited by 256
Cited by
Cost-of-illness studies of inherited retinal diseases: a systematic review
Ng, Q. X., Ong, C., Yaow, C. Y. L., Chan, H. W., Thumboo, J., Wang, Y., & Koh, G. C. H. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03099-9 · Cited by 27
“In the United States (US) alone, in 2017, the total economic burden of vision loss and blindness amounted to more than US$134 billion for the US population [8].”
BackgroundWatanabe, K., Aouadj, C., Hiratsuka, Y., Yamamoto, S., & Murakami, A. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02446-9 · Cited by 13
“…loss has been reported to be higher than indirect costs: one study estimated annual costs of 98.7 billion USD and indirect costs of 35.5 billion USD [34], and an earlier study of a population younger than 40 years estimated direct costs of 14.5 billion USD and indirect costs of 13 billion USD [35].”
InfluentialLeigh, J., Drinkwater, J., Turner, A., & Schroeder, E. (2026) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.70016 · Cited by 8
Diabetic retinopathy treatment cascade and care continuum in the USA: a systematic review
Fu, J. J., Applebaum, S. S., Granados, A., & Nwanyanwu, K. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-117683 · Cited by 1
“3 Our group reported an association between lack of awareness of DR and both longer diabetes duration and elevated haemoglobin A1c.”
Metadata
- Authors
- Rein, D. B., Wittenborn, J. S., Zhang, P., Sublett, F., Lamuda, P. A., Lundeen, E. A., & Saaddine, J.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 129
- Issue
- 4
- Pages
- 369-378
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W3200076617
- Cited by
- 128
- References
- 1
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Economic Burden of Vision Loss and Blindness in the United States. https://app.cochat.ai/papers/10.1016/j.ophtha.2021.09.010
- The paper
- Rein, D. B., Wittenborn, J. S., Zhang, P., Sublett, F., Lamuda, P. A., Lundeen, E. A., & Saaddine, J. (2022). The Economic Burden of Vision Loss and Blindness in the United States. Ophthalmology. https://doi.org/10.1016/j.ophtha.2021.09.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.